30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Genetic analysis, linkage, and association<br />

P0961. Mutational screening in Dysferlin gene<br />

L. Gonzalez-Quereda 1 , J. Juan 1 , N. de Luna 2 , E. Gallardo 2 , M. Rodriguez 1 , C.<br />

Paradas 3 , I. Illa 2 , M. Baiget 1 , P. Gallano 1 ;<br />

1 <strong>Genetics</strong>, Hospital de Sant Pau, Barcelona, Spain, 2 Neurology, Hospital de<br />

Sant Pau, Barcelona, Spain, 3 Neurology, Hospital de Valme, Sevilla, Spain.<br />

Mutations in dysferlin gene (DYSF) cause different muscular dystrophy<br />

phenotypes with autosomal recessive inheritance including Limb<br />

Girdle Muscular Dystrophy 2B (LGMD2B), Miyoshi Myopathy (MM)<br />

and Distal Anterior Compartment Myopathy (DAT). DYSF gene, that<br />

maps to chromosome 2p13, has 55 exons and codifies a protein of<br />

about 237 kDa.<br />

Dysferlin protein is expressed in skeletal muscle and peripheral blood<br />

monocytes. The genomic analysis of the DYSF gene has proved to<br />

be time consuming because its long size. We designed a mutational<br />

screening strategy based on cDNA from monocytes to find out whether<br />

the mutational analysis could be performed in mRNA from a source<br />

less invasive than the muscle biopsy<br />

We studied 50 patients from 31 families clinically diagnosed as MM,<br />

LGMD2B and DAT through: 1) the analysis of dysferlin expression by<br />

immunohystochemistry in muscle biopsies and Western blot in peripheral<br />

blood monocytes and, 2) the screening of mutations in DYSF gene<br />

by sequencing monocytes cDNA, amplifying 14 fragments that covers<br />

the 55 exons. Finally, the results were confirmed in genomic DNA.<br />

We identified mutations in DYSF gene in the thirty one families studied:<br />

17 of them in a homozygous state and 14 in a heterozygous state.<br />

We found the two mutated alleles in twenty eight families and only one<br />

mutated allele in 3 families. Seventeen mutations were missense, 10<br />

nonsense, 13 frameshit and 2 splice site mutations.<br />

This report furnish evidence of reliable mutational analysis using<br />

monocytes cDNA and constitutes a good alternative to genomic DNA<br />

analysis.<br />

P0962. Haplotypic classification of DEB in Tunisia: evidence for<br />

genetic variability among the different geographic regions<br />

H. Ouragini 1 , F. Cherif 2 , W. Daoud 2 , S. Kassar 3 , S. Nouira 1 , S. Boubaker 3 , A.<br />

Ben Osman-Dhahri 2 , S. Abdelhak 1 ;<br />

1 Molecular Investigation of Genetic Orphan Diseases, Institut Pasteur de Tunis,<br />

Tunis, Tunisia, 2 Dermatology department, Hôpital de la Rabta, Tunis, Tunisia,<br />

3 Anatomo-Pathology service, Institut Pasteur de Tunis, Tunis, Tunisia.<br />

The dystrophic epidermolysis bullosa (DEB), a group of heritable blistering<br />

skin diseases, is characterized by abnormalities in the anchoring<br />

fibrils at the dermal-epidermal basement membrane zone. Mutations<br />

within COL7A1 gene that encodes type VII collagen, the major component<br />

of the anchoring fibrils, is responsible for DEB.<br />

In order to study the mutational spectrum of DEB in Tunisia, we classify<br />

the DEB Tunisian patients on the basis of their haplotype. Thirty recessive<br />

DEB patients, belonging to 24 families, have been genotyped<br />

with five microsatellite markers overlapping the COL7A1 region.<br />

The genetic investigation showed that there are two common haplotypes,<br />

3-1-6-3-3 and 1-11-14-6-6, which are shared by 6 and 2 families<br />

respectively. The most frequent haplotype, 3-1-6-3-3, shared by 25%<br />

of the families, is mainly found among families originating from Central<br />

Tunisia, and the second one, 1-11-14-6-6, shared by 8% is found<br />

among families originating from North Eastern region. The other studied<br />

DEB patients have different haplotype and scattered on different<br />

cities of the country. All together, seven different haplotypes have been<br />

identified. This study shows haplotypic heterogeneity among Tunisian<br />

DEB families, thus suggesting a mutational heterogeneity.<br />

P0963. The ACE insertion/deletion genotype is associated with<br />

elite athletic performance<br />

R. E. Amir 1 , M. Sagiv 1 , E. Attias 1 , C. Yamin 1 , M. Sagiv 1 , Y. Meckel 1 , O. Amir 2 ;<br />

1 Zinman College of Physical education and sport sciences at the wingate institute,<br />

Netanya, Israel, 2 Lady Davis Carmel Medical Center, Haifa, Israel.<br />

Background: Growing evidence suggests a significant genetic contribution<br />

to human physical performance. The deletion (D) allele of angiotensin-I<br />

converting (ACE) gene has been associated with higher<br />

ACE activity. In the current study we evaluated the association between<br />

ACE ID polymorphism and elite endurance athletic ability.<br />

Methods: Ninety-two elite athletes, classified as either endurance type<br />

performers (51 long distance runners and triathletes) or power athletes<br />

(41 sprinters and long jumpers), were genotyped for the ACE ID polymorphism<br />

using polymerase chain reaction on leukocytes DNA. Their<br />

ACE genotypes were compared to those of 405 healthy individuals.<br />

Results: Allele and genotype frequencies differed significantly between<br />

the groups. The frequency of the D allele was 0.78 in the elite<br />

long distance runners and triathletes, 0.66 in the control group, and<br />

0.57 in the sprinters and long jumpers (Χ 2 = 10.04, P = 0.006). Moreover,<br />

the ACE DD genotype was significantly more prevalent among<br />

the long distance runners (0.63) compared to the controls (0.43), and<br />

compared to the sprinters and long jumpers (0.34) (Χ 2 = 21.99, P =<br />

0.0002). Importantly, in the group of elite athletes the odds ratio of ACE<br />

DD genotype for endurance performance was 3.24 (95% confidence<br />

interval 1.38-7.61), and of ACE II genotype was 0.25 (95% confidence<br />

interval 0.06-0.97).<br />

Conclusions: The present study clearly indicates a positive association<br />

of the ACE D allele with sustained high-level endurance performance.<br />

These data support the notion that increased ACE activity may be of<br />

benefit to endurance-type elite athletes.<br />

P0964. Association of TNF-alpha G-308A promoter<br />

polymorphism with human embryo viability<br />

M. S. Nazarenko, V. P. Puzyrev, I. N. Lebedev;<br />

State Research Institute of Medical <strong>Genetics</strong>, Tomsk, Russian Federation.<br />

Tumor necrosis factor alpha (TNF-alpha), a multifunctional cytokine, is<br />

expressed in embryonic tissues practically at all stages of human development.<br />

It is believed that TNF-alpha boosts death signaling to kill<br />

the embryo if damages triggered by detrimental stimuli may culminate<br />

in structural anomalies, and stimulate protective mechanisms if the repair<br />

of these damages may prevent maldevelopment. Nonetheless,<br />

no data about the influence of TNF-alpha G-308A promoter polymorphism<br />

for embryo viability itself are found. Samples of trophoblast tissue<br />

from delayed miscarriages (n=118) and dried blood spots of newborns<br />

(n=300) were analyzed for TNF-alpha G-308A polymorphism.<br />

The genotypes -308GA and -308AA TNF-alpha were more prevalent<br />

among newborns (24%) than in the group of delayed miscarriages<br />

(14.4%; P=0.03). Carriers of allele -308A predominated in the neonatal<br />

group to compare with delayed miscarriages (12,3% vs. 7,2%;<br />

P=0.04). In conclusion, high frequency of mutant TNF-alpha allele<br />

among newborns reflect the possible advantage for embryo survival,<br />

that in turn, may lead to its stable frequency in population.<br />

P0965. Polymorphism of IL4RA gene is associated with<br />

endometriosis<br />

M. A. Kozlovskaya 1,2 , G. S. Demin 1,2 , M. I. Yarmolinskaya 1 , T. E. Ivashchenko 1 ,<br />

V. S. Baranov 1,2 ;<br />

1 Ott’s Institute of Obstetrics & Gynecology, St.-Petersburg, Russian Federation,<br />

2 Saint-Petersburg State University, Saint-Petersburg, Russian Federation.<br />

Endometriosis is a common multifactorial disease. Typical endometrioid<br />

cells are characterized by increased cytokine activity. Cytokine<br />

genes are highly polymorphic that results in synthesis of proteins with<br />

various functional activities. This study is devoted to definition of role<br />

of allelic variants of IL4 and IL4RA genes in pathogenesis of endometriosis.<br />

DNA samples from the patients with endometriosis (n=36) and control<br />

group of women without any gynecologic complications (n=69) were<br />

included in the study. Polymorphisms of IL4 (-590T>C) and IL4RA<br />

(<strong>19</strong>02A>G or Gln551Arg) were defined by PCR-RFLP assay.<br />

The distribution of IL4 and IL4RA genotypes was in agreement with<br />

the HWE law (p>0.05). The frequencies of alleles and genotypes of<br />

IL4 gene did not differ between studied groups (p>0.05). However the<br />

frequency of Arg/Arg genotype of IL4RA gene was significantly higher<br />

in patients with endometriosis (<strong>16</strong>.7%) than in control group (1.4%,<br />

p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!